Patrick Avenet

Affiliations: 
Sanofi-Synthelabo Recherche, Bagneux, France, Bagneux, Île-de-France, France 
Area:
Drug discovery, neuroscience
Google:
"Patrick Avenet"
Mean distance: 14.3 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Griebel G, Pichat P, Beeské S, et al. (2015) Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents. Scientific Reports. 5: 7642
Griebel G, Ravinet-Trillou C, Beeské S, et al. (2014) Mice deficient in cryptochrome 1 (cry1 (-/-)) exhibit resistance to obesity induced by a high-fat diet. Frontiers in Endocrinology. 5: 49
Hortala L, Arnaud J, Roux P, et al. (2014) Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor. Bioorganic & Medicinal Chemistry Letters. 24: 283-7
Boulay D, Ho-Van S, Bergis O, et al. (2013) Phencyclidine decreases tickling-induced 50-kHz ultrasound vocalizations in juvenile rats: a putative model of the negative symptoms of schizophrenia? Behavioural Pharmacology. 24: 543-51
Griebel G, Beeské S, Jacquet A, et al. (2013) Further evidence for the sleep-promoting effects of 5-HT₂A receptor antagonists and demonstration of synergistic effects with the hypnotic, zolpidem in rats. Neuropharmacology. 70: 19-26
Biton B, Sethuramanujam S, Picchione KE, et al. (2012) The antipsychotic drug loxapine is an opener of the sodium-activated potassium channel slack (Slo2.2). The Journal of Pharmacology and Experimental Therapeutics. 340: 706-15
Boulay D, Bergis O, Avenet P, et al. (2010) The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 416-27
Claustre Y, Leonetti M, Santucci V, et al. (2008) Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile. Neuroscience. 156: 353-64
Boulay D, Pichat P, Dargazanli G, et al. (2008) Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacology, Biochemistry, and Behavior. 91: 47-58
Stemmelin J, Cohen C, Terranova JP, et al. (2008) Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 574-87
See more...